ADO 0.00% 2.1¢ anteotech ltd

Nanotechnology innovation in Point of Care testing - by Marcel van Kasteel, CEO Handheld Diagnostic, page-18

  1. 5,687 Posts.
    BBI - lateral flow tests with Mix & Go "rivalled those that are achieved, for the antibodies tested, in laboratory-based test"

    POC1 - instrument based tests "expected to deliver a range of test performance levels that are comparable to many laboratory-based tests"

    So ADO have both camps covered.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.